‘A Cell’s Life’: the comic strip demystifying Parkinson’s research
Resources & Tools
Author: Almaz OhenePublished: 22 February 2018
Prep: Cook: Serves:
The science behind stem cell treatment can often be difficult to explain. ERCcOMICS is a web comic series from the European Research Council (ERC), which aims to use comic strip storytelling to demystify research
Is a cure for Parkinson’s or Alzheimer’s just around the corner? To find out, the European Research Council (ERC) is funding cutting-edge research into stem cell treatments and has commissioned an online comic series which explains the findings.
The web comics series, ‘A Cell’s Life’, follows the fate of Jojo, an epidermal (skin) cell whose dream has always been to become a neuron (brain) cell. Jojo is frustrated by the routine of his skin cell work, until his life changes and he’s drafted in to join the stem cell team. Over the course of the 10-part series, the fate of Jojo’s human ‘host’ – diagnosed with Parkinson’s at the story’s opening – is revealed.
Click the image below to watch the teaser video.
The research explored in the comic is carried out by Dr Malin Parmar, professor of developmental and regenerative neurobiology at Lund University, Sweden. Parkinson’s disease is caused by the premature death of dopamine neurons, and Dr Parmar has been testing new stem cell treatment methods that directly re-programme cells into functioning neurons.
Her work involves reprogramming adult skin cells directly into dopaminergic cells – collections of neurons that contain dopamine – and inserting genes into the brain to repair and substitute damaged cells on the spot.
Episode eight will be released today. To read the comic, which is best viewed on a computer rather than a mobile or tablet, follow this link: ‘A Cell’s Life‘.
Malin Parmar (researcher)
Dr Malin Parmar is a professor at Lund University, Sweden, where she is focusing on bringing new cell-based therapies for Parkinson’s disease to the clinic by replacing lost dopamine neurons with new, healthy cells. Her work in cellular reprogramming opens up the possibilities of personalised treatments of patients with healthy versions of their own cells.
Alessandro Tota (artist)
Alessandro Tota is an illustrator and a cartoonist, who lives and works in Paris. He is one of the founders of the magazine ‘Canicola’. His work has been exhibited in Bologna, Modena, Naples, Milan, Helsinki, Paris, Lucerne, Leipzig and Hamburg.
Fiamma Luzzati (storyboard artist)
Fiamma Luzzati is from Italy and now lives in Paris. She is a specialist in scientific communication comics
For comprehensive information about stem cell treatment please visit Parkinson’s Europe website.
Neurological disorders – including Parkinson’s – are leading source of disability globally
Parkinson’s is world’s fastest growing neurological disorder
6 days ago
Could Parkinson’s disease originate in the gut?
A new body of research has highlighted a potential link between gut health and Parkinson’s, with several studies presented at the Society for Neuroscience’s annual meeting in San Diego, US. One study focused on alpha-synuclein – a protein that can cause brain cells to die and contribute to the condition’s onset. As part of the study, the researchers created a mouse model of Parkinson’s by treating the mice with rotenone (an ingredient used in pesticides). This was found to increase clumps of alpha-synuclein in the gut, suggesting the protein may originate in the digestive system before moving to the brain. Commenting on the research presented at the event in a press release, assistant professor of neurosurgery Sonia Villapol said: “When it comes to neurological disorders, we cannot target only the brain. Everything that happens in the gut has an impact on the brain.”
Is dry eye disease common in people with Parkinson’s?
Dry eye disease can involve symptoms such as a lower blinking rate and typically occurs when the eyes are not effectively moistened by tears – leading to discomfort and possible vision loss. Now, a recent study from Japan has investigated the previously underexplored relationship between dry eye disease and Parkinson’s. As part of their research, the team analysed 13 studies published between 2004 and 2022, which involved more than 1,500 people with Parkinson’s. Five of the reports highlighted the prevalence of dry eye disease in people with the condition – with 61% experiencing symptoms. “Our findings emphasize the need for clinicians to be vigilant of the presence of dry eye disease when managing [people with Parkinson’s],” the researchers wrote. However, they noted that more research is needed – especially “future large-scale studies” – to help understand the relationship between dry eye disease and the condition.
Highlighting dental care needs among people with Parkinson’s disease
Researchers from the University of Copenhagen, Denmark, have published a new study looking into dental care among people with Parkinson’s. Using a national register to obtain data relating to dental care between 2015 and 2019, the team identified 6,874 people with Parkinson’s, whose data was then compared to a control group of 34,285 people without the condition. A key takeaway from the five-year study was that a larger portion of people with Parkinson’s were not regular users of the dental care system – 21%, compared to 16.9% in the control group. The findings published in the journal ‘Community Dentistry and Oral Epidemiology’ also revealed that people with Parkinson’s utilised more dental-related treatment services than those in the control group – such as fillings and extractions. The researchers concluded: “This knowledge can be used by clinicians and decision-makers to ensure the optimal dental care for persons with Parkinson’s.”